Acta Scientific Pharmacology

Editorial Article Volume 3 Issue 6

Stroke - An Emergent Complication of Covid-19 Disease

Dr Ch OV Nagateja* and Dr Hari Chandana

Doctor of Pharmacy, Clinical Pharmacist, Clinical Researcher, Clinical Data Analyst, India

*Corresponding Author:Dr Ch OV Nagateja Doctor of Pharmacy, Clinical Pharmacist, Clinical Researcher, Clinical Data Analyst, India.

Received: March 24, 2022 Published: May 01, 2022

Coronavirus disease 2019 (COVID-19) is a viral infection caused by Severe acute respiratory illness (SARS-CoV-2). Wuhan, China, was the first country to report it. The appearance and spread of the extremely contagious new coronavirus disease (COVID-19) has sparked the century's greatest public health issue.

Despite the fact that COVID-19 is largely a respiratory infection, research indicate that it can cause hypercoagulability and thrombotic consequences. During the COVID-19 epidemic, stroke remained a medical emergency.

References

Citation

Citation: Dr Ch OV Nagateja and Dr Hari Chandana. “Stroke - An Emergent Complication of Covid-19 Disease". Acta Scientific Pharmacology 3.6 (2022): 01-02.

Copyright

Copyright: © 2022 Dr Ch OV Nagateja and Dr Hari Chandana. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.





Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US